Drug company and former director are convicted of submitting falsified data to MHRA

The drug company Kappin and its former director Kamlesh Vaghjiani have been successfully prosecuted for knowingly providing false data to the UK’s drug regulator, the Medicines and Healthcare Products Regulatory Agency (MHRA), to obtain and then retain marketing authorisation for a hypothyroidism treatment.In a UK first Vaghjiani and Kappin have been fined £50 000, having previously paid out nearly £1.1m that they made in profits from the crime. The drug company must pay the prosecution costs of £82 262.At Southwark Crown Court in London on 15 March Vaghjiani was also handed down two suspended sentences of eight months and seven months for two counts of falsifying data, to run concurrently. In October last year he and the company changed their pleas to guilty on all charges.The MHRA’s deputy director for criminal enforcement, Andy Morling, said, “This is a shocking case of a pharmaceutical company that thought it was above the…
Read Original Article: Drug company and former director are convicted of submitting falsified data to MHRA »